Zobrazeno 1 - 10
of 69
pro vyhledávání: '"BRAGGSS"'
Autor:
James OIiver, Nisha Nair, Gisela Orozco, Samantha Smith, Kimme L. Hyrich, Ann Morgan, John Isaacs, Anthony G. Wilson, BRAGGSS, Anne Barton, Darren Plant
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-9 (2021)
Abstract Background Despite the success of TNF-inhibitor therapy in rheumatoid arthritis treatment, up to 40% of patients fail to respond adequately. This study aimed to identify transcriptome-based biomarkers of adalimumab response in rheumatoid art
Externí odkaz:
https://doaj.org/article/bbb58074afc94d84ac2543b97fb97e06
Autor:
James Oliver, Nisha Nair, Gisela Orozco, Samantha Smith, Kimme L. Hyrich, Ann Morgan, John Isaacs, Anthony G. Wilson, BRAGGSS, Anne Barton, Darren Plant
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/f2efa8ebdc5a4f27a1c4c2f062fb77b2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hum, Ryan M, Ho, Pauline, Nair, Nisha, Jani, Meghna, Morgan, Ann W, Isaacs, John D, Wilson, Anthony G, Hyrich, Kimme L, Plant, Darren, Barton, Anne, Collaborators, the BRAGGSS
Publikováno v:
Rheumatology; Jun2023, Vol. 62 Issue 6, p2090-2097, 8p
Autor:
Sarah Leggett, James M. Gwinnutt, Anne Barton, Karen Walker-Bone, Kimme L. Hyrich, Braggss co-investigators, Suzanne M M Verstappen, Rams, Mark Lunt
Publikováno v:
Rheumatology (Oxford, England)
Gwinnutt, J, Leggett, S, Lunt, M, Barton, A, Hyrich, K, Walker-Bone, K & Verstappen, S 2020, ' Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis ', Rheumatology (Oxford) . https://doi.org/10.1093/rheumatology/keaa027
Gwinnutt, J, Leggett, S, Lunt, M, Barton, A, Hyrich, K, Walker-Bone, K & Verstappen, S 2020, ' Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis ', Rheumatology (Oxford) . https://doi.org/10.1093/rheumatology/keaa027
ObjectivesWork is an important health outcome. This study aimed to identify predictors of work loss, absenteeism and presenteeism over 1 year in RA patients commencing treatment with MTX or biologics.MethodsPatients aged 18–65 years in full/part-ti
Autor:
Ryan Malcolm Hum, Pauline Ho, Nisha Nair, Meghna Jani, Ann W. Morgan, John D. Isaacs, Anthony G. Wilson, Kimme L. Hyrich, Darren Plant, Anne Barton, BRAGGSS Collaborators
Publikováno v:
SSRN Electronic Journal.
Autor:
Gilani, SSA, Nair, N, Plant, D, Hyrich, K, Morgan, A, Morris, AP, Wilson, AG, Isaacs, JD, Barton, A, Bluett, J, BRAGGSS Consortium
Aim: TNF inhibitor drugs are a treatment option for rheumatoid arthritis, but response is not universal. Response is typically measured using the composite 4-component (4C) disease activity score 28 (DAS28) which contains more subjective measures. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f275535fcfbdc435e3225375290a1079
https://eprints.whiterose.ac.uk/166807/10/pgs-2020-0043(1).pdf
https://eprints.whiterose.ac.uk/166807/10/pgs-2020-0043(1).pdf
Autor:
Dagliati, A, Plant, D, Nair, N, Jani, M, Amico, B, Peek, N, Morgan, AW, Isaacs, J, Wilson, AG, Hyrich, KL, Geifman, N, Barton, A, BRAGGSS
Objectives: To determine whether using a re‐weighted disease activity score that better reflects joint synovitis, the 2‐component DAS28 (2C‐DAS28), based on 28‐swollen joint count and C‐reactive protein, produces more clinically relevant tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::058e8e24d7202380283d5b03992beb56
Autor:
Jani, M, Isaacs, JD, Morgan, AW, Wilson, AG, D, Plant., Hyrich, KL, Chinoy, H, Barton, A, Braggss
Publikováno v:
Annals of the rheumatic diseases
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
Objectives To evaluate (i) the association between random certolizumab drug levels, antidrug antibodies (ADAbs) and treatment response in patients with rheumatoid arthritis (RA); (ii) longitudinal factors associated with ADAbs and certolizumab drug l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3a0c287d2215fc3d9840efacb553f62a
https://doi.org/10.1136/annrheumdis-2015-208849
https://doi.org/10.1136/annrheumdis-2015-208849